Program
olezarsen
Also written as “Olezarsen”, “Cyclosporine Capsules USP (Modified) 100 mg” and “ISIS 678354”.
Its studies are mostly in Hypertriglyceridemia, led by 2 companies.
Drug pageOlezarsen: every studyAll 13 studies of it, academic ones too, with its approvals, label and forms.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Ionis Pharmaceuticalsits history only | 114 open or running | phase 3since Sep 23, 2020 | Dec 1, 2017 | Mar 2027phase 3 · NCT05681351 |
| Panacea Biotec | 20 open or running | no phasesince Mar 2, 2010 | Mar 2, 2010 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Panacea Biotec only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). An open circle marks the day WHO proposed its name. Dates ahead are the sponsors’ estimates.
- Mar 2, 2010First studies: 2 no phase studies in Healthy VolunteersFirst studyNCT01080586, NCT01080560
- Jul 28, 2021Named olezarsenINNProposed as its International Nonproprietary Name in WHO's List 125 · before, ISIS 678354
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 2 Panacea Biotec leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT01080586Healthy Volunteers · India | – | Completed | Sep 2007 | 36 |
| NCT01080560Healthy Volunteers · India | – | Completed | Sep 2007 | 36 |
How it is read
Names in the registry
- “Olezarsen”, 10 entries
- “Cyclosporine Capsules USP (Modified) 100 mg”, 2 entries
- “ISIS 678354”, 1 entry
Conditions, from the studies’ own filings
- Hypertriglyceridemia, 6 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.